This week, Safeguard Scientifics’ life sciences team is in San Francisco attending J.P. Morgan’s 30th Annual Healthcare Conference, one of the healthcare industry’s largest annual meetings. The team is also spending time at partneringONE’s...

In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011, Alverix announced that its partner Becton, Dickinson and Company (BD) has received 510(k)...

Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious. Entrepreneur Magazine even goes so far as to ask whether venture...

At Safeguard Scientifics, we offer our partner companies quality resources to promote their growth and help them recruit strong management teams for their future. We currently have 16 partner companies, and we strive to provide each of them with operational...

The past 12 months have exciting at Safeguard Scientifics. In December of 2010, partner companies Clarient and Avid Radiopharmaceuticals were both acquired by giants in the life sciences industry. Safeguard experienced the largest cash return in our 58-year...

Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that we believe will have success with applications they submit to the FDA. In addition,...